JP2023515927A5 - - Google Patents

Info

Publication number
JP2023515927A5
JP2023515927A5 JP2022549759A JP2022549759A JP2023515927A5 JP 2023515927 A5 JP2023515927 A5 JP 2023515927A5 JP 2022549759 A JP2022549759 A JP 2022549759A JP 2022549759 A JP2022549759 A JP 2022549759A JP 2023515927 A5 JP2023515927 A5 JP 2023515927A5
Authority
JP
Japan
Prior art keywords
composition according
nanoparticles
nucleic acid
cationic lipid
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022549759A
Other languages
English (en)
Japanese (ja)
Other versions
JP7895101B2 (ja
JP2023515927A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/018831 external-priority patent/WO2021168290A1/en
Publication of JP2023515927A publication Critical patent/JP2023515927A/ja
Publication of JP2023515927A5 publication Critical patent/JP2023515927A5/ja
Priority to JP2026018905A priority Critical patent/JP2026097824A/ja
Application granted granted Critical
Publication of JP7895101B2 publication Critical patent/JP7895101B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022549759A 2020-02-19 2021-02-19 免疫チェックポイント阻害剤による治療に対して腫瘍を感作させる多重膜rnaナノ粒子および方法 Active JP7895101B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026018905A JP2026097824A (ja) 2020-02-19 2026-02-06 免疫チェックポイント阻害剤による治療に対して腫瘍を感作させる多重膜rnaナノ粒子および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062978694P 2020-02-19 2020-02-19
US62/978,694 2020-02-19
PCT/US2021/018831 WO2021168290A1 (en) 2020-02-19 2021-02-19 Multilamellar rna nanoparticles and methods of sensitizing tumors to treatment with immune checkpoint inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026018905A Division JP2026097824A (ja) 2020-02-19 2026-02-06 免疫チェックポイント阻害剤による治療に対して腫瘍を感作させる多重膜rnaナノ粒子および方法

Publications (3)

Publication Number Publication Date
JP2023515927A JP2023515927A (ja) 2023-04-17
JP2023515927A5 true JP2023515927A5 (cg-RX-API-DMAC7.html) 2024-02-27
JP7895101B2 JP7895101B2 (ja) 2026-07-27

Family

ID=77392250

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022549759A Active JP7895101B2 (ja) 2020-02-19 2021-02-19 免疫チェックポイント阻害剤による治療に対して腫瘍を感作させる多重膜rnaナノ粒子および方法
JP2026018905A Pending JP2026097824A (ja) 2020-02-19 2026-02-06 免疫チェックポイント阻害剤による治療に対して腫瘍を感作させる多重膜rnaナノ粒子および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026018905A Pending JP2026097824A (ja) 2020-02-19 2026-02-06 免疫チェックポイント阻害剤による治療に対して腫瘍を感作させる多重膜rnaナノ粒子および方法

Country Status (6)

Country Link
US (1) US20230346700A1 (cg-RX-API-DMAC7.html)
EP (1) EP4106730A4 (cg-RX-API-DMAC7.html)
JP (2) JP7895101B2 (cg-RX-API-DMAC7.html)
AU (1) AU2021222036A1 (cg-RX-API-DMAC7.html)
CA (1) CA3168509A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021168290A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7783628B2 (ja) * 2019-07-19 2025-12-10 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 多層rnaナノ粒子
US20250231177A1 (en) * 2022-04-04 2025-07-17 University Of Florida Research Foundation, Inc. Method of characterizing tumors
WO2025207807A1 (en) * 2024-03-27 2025-10-02 The University Of Florida Research Foundation, Inc. Ctc rna-loaded nanoparticles and use thereof for the treatment of cancer
WO2025207936A1 (en) * 2024-03-28 2025-10-02 Mirror Biologics, Inc. Treatment for colorectal cancer using immune checkpoint inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3364949A4 (en) * 2015-10-22 2019-07-31 ModernaTX, Inc. CANCER VACCINES
PL3458083T3 (pl) * 2016-05-18 2023-03-13 Modernatx, Inc. Polinukleotydy kodujące interleukinę-12 (il12) i ich zastosowania
CA3050614A1 (en) * 2017-03-17 2018-09-20 Curevac Ag Rna vaccine and immune checkpoint inhibitors for combined anticancer therapy
CN112367974A (zh) 2018-05-15 2021-02-12 DNALite治疗学公司 粘液穿透肽、递送媒介和治疗方法
WO2020037102A1 (en) * 2018-08-15 2020-02-20 University Of Florida Research Foundation, Inc. Methods of sensitizing tumors to treatment with immune checkpoint inhibitors
JP7783628B2 (ja) * 2019-07-19 2025-12-10 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 多層rnaナノ粒子

Similar Documents

Publication Publication Date Title
Lu et al. Nucleic acid drug vectors for diagnosis and treatment of brain diseases
Liu et al. Targeted exosome coating gene-chem nanocomplex as “nanoscavenger” for clearing α-synuclein and immune activation of Parkinson’s disease
Li et al. The roles of exosomes in cancer drug resistance and its therapeutic application
JP6023126B2 (ja) 標的遺伝子の発現を抑制する組成物
Tagami et al. Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA
Tyagi et al. Exploiting nanotechnology for the development of microRNA-based cancer therapeutics
Huang et al. In vivo delivery of RNAi with lipid-based nanoparticles
US9574210B2 (en) Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
JP2022528487A (ja) C9orf72のオリゴヌクレオチドベースの調節
Lu et al. Environment‐responsive lipid/siRNA nanoparticles for cancer therapy
WO2016145008A2 (en) Mirna for treatment of breast cancer
CN102112136A (zh) 抑制靶基因表达的组合物
JP2023512707A5 (cg-RX-API-DMAC7.html)
Fu et al. Research progress in exosome-based nanoscale drug carriers in tumor therapies
JP2021523145A5 (cg-RX-API-DMAC7.html)
JP2025138644A5 (cg-RX-API-DMAC7.html)
WO2019043709A9 (en) COMPOSITIONS AND METHODS FOR TREATING FIBROTIC DISEASES
WO2017067188A1 (zh) 一种药物组合物及其应用
Soleimani et al. CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice
Liu et al. A macrophage plasma membrane-coated and DNA structured nanomedicine targets to alleviate rheumatoid arthritis via dual inhibition to TNF-α and NF-κB
Zhang et al. Nanotherapeutic Approaches of Interleukin‐3 to Clear the α‐Synuclein Pathology in Mouse Models of Parkinson's Disease
WO2021016106A8 (en) Multilamellar rna nanoparticles
CN108175861A (zh) 一种抗肿瘤小核酸药物的递送系统及其应用
Do et al. Delivery of LOXL1-AS1-siRNAs using targeting peptide-engineered extracellular vesicles with focused ultrasound to suppress medulloblastoma metastasis
CN120641564A (zh) 用于抑制腺苷酸环化酶9(ac9)的组合物和方法